These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 27544712)

  • 21. Relationship between recent short-acting beta-agonist use and subsequent asthma exacerbations.
    Paris J; Peterson EL; Wells K; Pladevall M; Burchard EG; Choudhry S; Lanfear DE; Williams LK
    Ann Allergy Asthma Immunol; 2008 Nov; 101(5):482-7. PubMed ID: 19055201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial.
    Papi A; Corradi M; Pigeon-Francisco C; Baronio R; Siergiejko Z; Petruzzelli S; Fabbri LM; Rabe KF
    Lancet Respir Med; 2013 Mar; 1(1):23-31. PubMed ID: 24321801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM; Culler SD; Ershoff D; Gutierrez B
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhaler reminders improve adherence with controller treatment in primary care patients with asthma.
    Foster JM; Usherwood T; Smith L; Sawyer SM; Xuan W; Rand CS; Reddel HK
    J Allergy Clin Immunol; 2014 Dec; 134(6):1260-1268.e3. PubMed ID: 25062783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
    Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K
    Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial.
    Patel M; Pilcher J; Pritchard A; Perrin K; Travers J; Shaw D; Holt S; Harwood M; Black P; Weatherall M; Beasley R;
    Lancet Respir Med; 2013 Mar; 1(1):32-42. PubMed ID: 24321802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative effectiveness of budesonide-formoterol combination and fluticasone-salmeterol combination for asthma management: a United States retrospective database analysis.
    Tunceli O; Williams SA; Kern DM; Elhefni H; Pethick N; Wessman C; Zhou S; Trudo F
    J Allergy Clin Immunol Pract; 2014; 2(6):719-26. PubMed ID: 25439363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between episodes of upper respiratory infection and exacerbations in adult patients with asthma.
    Tomita K; Sano H; Iwanaga T; Ishihara K; Ichinose M; Kawase I; Kimura H; Hirata K; Fujimura M; Mishima M; Tohda Y
    J Asthma; 2012 Apr; 49(3):253-9. PubMed ID: 22376075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative study of efficacy of salbutamol via metered dose inhaler with volumatic spacer and via dry powder inhaler, easyhaler, to nebulization in mild to moderate severity acute asthma exacerbation in childhood.
    Vangveeravong M
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S115-23. PubMed ID: 19253506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study.
    Silkoff PE; Strambu I; Laviolette M; Singh D; FitzGerald JM; Lam S; Kelsen S; Eich A; Ludwig-Sengpiel A; Hupp GC; Backer V; Porsbjerg C; Girodet PO; Berger P; Leigh R; Kline JN; Dransfield M; Calhoun W; Hussaini A; Khatri S; Chanez P; Susulic VS; Barnathan ES; Curran M; Das AM; Brodmerkel C; Baribaud F; Loza MJ
    Respir Res; 2015 Nov; 16():142. PubMed ID: 26576744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting changes in clinical status of young asthmatics: clinical scores or objective parameters?
    Leung TF; Ko FW; Wong GW; Li CY; Yung E; Hui DS; Lai CK
    Pediatr Pulmonol; 2009 May; 44(5):442-9. PubMed ID: 19382219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different Severity and Severity Predictors in Early-Onset and Late-Onset Asthma: A Taiwanese Population-Based Study.
    Wu TJ; Chen BY; Lee YL; Hsiue TR; Wu CF; Guo YL
    Respiration; 2015; 90(5):384-92. PubMed ID: 26418355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective predictors of exacerbation status in severe asthma over a 3-year follow-up.
    Kimura H; Konno S; Makita H; Taniguchi N; Shimizu K; Suzuki M; Kimura H; Goudarzi H; Nakamaru Y; Ono J; Ohta S; Izuhara K; Ito YM; Wenzel SE; Nishimura M;
    Clin Exp Allergy; 2018 Sep; 48(9):1137-1146. PubMed ID: 29781543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The strategy for predicting future exacerbation of asthma using a combination of the Asthma Control Test and lung function test.
    Sato R; Tomita K; Sano H; Ichihashi H; Yamagata S; Sano A; Yamagata T; Miyara T; Iwanaga T; Muraki M; Tohda Y
    J Asthma; 2009 Sep; 46(7):677-82. PubMed ID: 19728204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advancing assessment of asthma control with a composite tool: The Asthma Impairment and Risk Questionnaire.
    Chipps BE; Zeiger RS; Beuther DA; Wise RA; McCann W; Reibman J; George M; Gilbert I; Eudicone JM; Coyne KS; Harding G; Murphy KR
    Ann Allergy Asthma Immunol; 2024 Jul; 133(1):49-56. PubMed ID: 38494113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors and predictive clinical scores for asthma exacerbations in childhood.
    Forno E; Fuhlbrigge A; Soto-Quirós ME; Avila L; Raby BA; Brehm J; Sylvia JM; Weiss ST; Celedón JC
    Chest; 2010 Nov; 138(5):1156-65. PubMed ID: 20472862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of asthma control: the SERENA study.
    Corrado A; Renda T; Polese G; Rossi A;
    Respir Med; 2013 Nov; 107(11):1659-66. PubMed ID: 24045118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive factors for moderate or severe exacerbations in asthma patients receiving outpatient care.
    Gutiérrez FJÁ; Galván MF; Gallardo JFM; Mancera MB; Romero BR; Falcón AR
    BMC Pulm Med; 2017 May; 17(1):77. PubMed ID: 28464895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severity of asthma score predicts clinical outcomes in patients with moderate to severe persistent asthma.
    Eisner MD; Yegin A; Trzaskoma B
    Chest; 2012 Jan; 141(1):58-65. PubMed ID: 21885725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma.
    Ivanova JI; Bergman R; Birnbaum HG; Colice GL; Silverman RA; McLaurin K
    J Allergy Clin Immunol; 2012 May; 129(5):1229-35. PubMed ID: 22326484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.